191 results
Page 5 of 10
8-K
EX-99.1
bqwq5u2k
29 Jun 20
Hepion Pharmaceuticals Announces Advancement to Final Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431
12:00am
8-K
EX-99.1
sydy4d7 dnpgzymv
22 Jun 20
Other Events
4:54pm
8-K
EX-99.1
90569q2dzixxugy
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-99.1
1j4bnckhswfziwrix5h
20 May 20
Hepion Pharmaceuticals Announces Advancement to Fourth Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431
4:35pm
8-K
EX-99.1
xwp pitxtdu
19 May 20
Other Events
8:12am
424B5
jswl3k 24776w
26 Mar 20
Prospectus supplement for primary offering
9:33pm
8-K
EX-99.1
nxtwjhpfwb7u8
12 Mar 20
Other Events
8:47am
8-K
EX-99.1
0h24d6lulncxif
20 Feb 20
Other Events
9:12am
8-K
EX-99.1
zi22fk6xc3d57k6
12 Feb 20
Hepion Pharmaceuticals Announces Advancement to Third Dose Level in Ongoing Multiple
4:24pm
424B5
kwjct15 j7t
12 Feb 20
Prospectus supplement for primary offering
9:05am
8-K
EX-99.1
pefez
28 Jan 20
Other Events
4:24pm
8-K
EX-99.1
nrzpm
9 Jan 20
Hepion Pharmaceuticals Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference
12:00am
8-K
EX-99.1
dspkxn9x
4 Dec 19
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments
12:00am
8-K
EX-99.2
ixoz1l2r3 eg
3 Dec 19
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
cv22npr32awm101q9dz
20 Nov 19
Other Events
9:27pm
8-K
EX-99.1
gzxcno76j0x
8 Nov 19
Hepion Pharmaceuticals to Present at The Liver MeetingÒ 2019
12:00am
8-K
EX-99.1
27b8kc
7 Nov 19
Other Events
12:55pm
8-K
EX-99.1
lu1ybfc7x61 r8
23 Oct 19
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit
4:29pm